(19)
(11) EP 2 197 916 A1

(12)

(43) Date of publication:
23.06.2010 Bulletin 2010/25

(21) Application number: 08804245.2

(22) Date of filing: 16.09.2008
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61P 19/02(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/EP2008/062286
(87) International publication number:
WO 2009/040268 (02.04.2009 Gazette 2009/14)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 24.09.2007 GB 0718684
24.09.2007 US 974641 P

(71) Applicant: F. Hoffmann-La Roche AG
4070 Basel (CH)

(72) Inventor:
  • CLOSE, David Robert
    Shire Park Hertfordshire AL7 1TW (GB)

(74) Representative: Heiroth, Ulrike Hildegard 
F. Hoffmann-La Roche AG Patent Department
4070 Basel
4070 Basel (CH)

   


(54) FIXED SINGLE INJECTION DOSAGE FOR OCRELIZUMAB (2H7)